BlueCrest Capital Management Ltd Takes Position in Davita Inc (DVA)

BlueCrest Capital Management Ltd bought a new stake in shares of Davita Inc (NYSE:DVA) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 30,624 shares of the company’s stock, valued at approximately $2,213,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. OppenheimerFunds Inc. grew its stake in Davita by 5,292.6% during the fourth quarter. OppenheimerFunds Inc. now owns 1,873,918 shares of the company’s stock valued at $135,391,000 after acquiring an additional 1,839,168 shares in the last quarter. Geode Capital Management LLC grew its stake in Davita by 1.0% during the fourth quarter. Geode Capital Management LLC now owns 1,609,652 shares of the company’s stock valued at $116,051,000 after acquiring an additional 16,017 shares in the last quarter. First Trust Advisors LP grew its stake in Davita by 5.1% during the fourth quarter. First Trust Advisors LP now owns 650,039 shares of the company’s stock valued at $46,965,000 after acquiring an additional 31,743 shares in the last quarter. Schwab Charles Investment Management Inc. grew its stake in Davita by 2.4% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 587,575 shares of the company’s stock valued at $42,453,000 after acquiring an additional 14,040 shares in the last quarter. Finally, California Public Employees Retirement System grew its stake in Davita by 4.4% during the fourth quarter. California Public Employees Retirement System now owns 511,756 shares of the company’s stock valued at $36,974,000 after acquiring an additional 21,624 shares in the last quarter. 85.80% of the stock is owned by institutional investors.

How to Become a New Pot Stock Millionaire

Several equities analysts recently weighed in on the stock. Robert W. Baird reaffirmed a “buy” rating and set a $95.00 target price (up from $82.00) on shares of Davita in a research note on Friday, January 12th. Bank of America reaffirmed a “buy” rating and set a $92.00 target price (up from $85.00) on shares of Davita in a research note on Thursday, January 11th. TheStreet raised shares of Davita from a “c” rating to a “b-” rating in a research note on Thursday, January 4th. SunTrust Banks reaffirmed a “hold” rating and set a $80.00 target price on shares of Davita in a research note on Wednesday, February 14th. Finally, Zacks Investment Research cut shares of Davita from a “buy” rating to a “hold” rating in a research note on Tuesday, February 13th. Two analysts have rated the stock with a sell rating, five have issued a hold rating, four have assigned a buy rating and two have assigned a strong buy rating to the company. Davita has an average rating of “Hold” and a consensus target price of $79.30.

DVA stock traded down $2.15 during trading on Monday, hitting $63.79. 2,434,508 shares of the company’s stock traded hands, compared to its average volume of 1,571,323. Davita Inc has a 52 week low of $52.51 and a 52 week high of $80.71. The company has a quick ratio of 2.82, a current ratio of 2.88 and a debt-to-equity ratio of 1.87. The firm has a market capitalization of $12,001.08, a P/E ratio of 19.21, a price-to-earnings-growth ratio of 0.95 and a beta of 1.09.

Davita (NYSE:DVA) last released its quarterly earnings data on Tuesday, February 13th. The company reported $0.92 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.94 by ($0.02). Davita had a net margin of 4.65% and a return on equity of 12.86%. The business had revenue of $2.78 billion for the quarter, compared to the consensus estimate of $3.90 billion. During the same quarter last year, the business earned $0.98 EPS. analysts anticipate that Davita Inc will post 4.15 EPS for the current year.

In other news, insider James K. Hilger sold 3,572 shares of the firm’s stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $78.95, for a total value of $282,009.40. Following the completion of the sale, the insider now owns 33,649 shares in the company, valued at approximately $2,656,588.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 2.00% of the stock is owned by company insiders.

COPYRIGHT VIOLATION NOTICE: “BlueCrest Capital Management Ltd Takes Position in Davita Inc (DVA)” was originally posted by Enterprise Leader and is the property of of Enterprise Leader. If you are reading this report on another domain, it was copied illegally and republished in violation of US and international copyright & trademark legislation. The legal version of this report can be accessed at https://theenterpriseleader.com/2018/04/02/bluecrest-capital-management-ltd-purchases-new-stake-in-davita-inc-dva.html.

Davita Profile

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Institutional Ownership by Quarter for Davita (NYSE:DVA)

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply